KEAP1 and non-small cell lung carcinoma: For example, by using broadly cysteine-reactive fragments as “scout fragments”,54 they examined proteomic cysteine ligandability in KEAP1-mutant and KEAP1-wild-type (WT) human non-small cell lung cancer (NSCLC) cell lines.